Cervical Cancer Screening
Boston University · Boston Medical Center · +4 more institutions
Abstract
Importance Each year in the US, approximately 100 000 people are treated for cervical precancer, 14 000 people are diagnosed with cervical cancer, and 4000 die of cervical cancer. Observations Essentially all cervical cancers worldwide are caused by persistent infections with one of 13 carcinogenic human papillomavirus (HPV) genotypes: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68. HPV vaccination at ages 9 through 12 years will likely prevent more than 90% of cervical precancers and cancers. In people with a cervix aged 21 through 65 years, cervical cancer is prevented by screening for and treating cervical precancer, defined as high-grade squamous intraepithelial lesions of the cervix. High-grade…
Citation impact
- FWCI
- 86.60
- Percentile
- 100%
- References
- 92
Authors
4- RBRebecca B. PerkinsCorresponding
Boston University, Boston Medical Center
- NWNicolas Wentzensen
National Cancer Institute, Division of Cancer Epidemiology and Genetics
- RSRichard S. Guido
University of Pittsburgh, Magee-Womens Hospital
- MSMark Schiffman
National Cancer Institute, Division of Cancer Epidemiology and Genetics
Topics & keywords
- Medicine
- Colposcopy
- Squamous intraepithelial lesion
- Cervical cancer
- Cervix
- Papanicolaou stain
- Gynecology
- Population
- Good health and well-being